Evidence map›Paper›PMID 40360559›Full record

ArticleNature communications2025

Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, Gustavo E Velásquez, Payam Nahid, Andrew Vernon, Ekaterina V Kurbatova, Susan Swindells, Richard E Chaisson, Susan E Dorman and 18 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Vincent K ChangDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Marjorie Z ImperialDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Patrick P J PhillipsUCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-6336-7024
Gustavo E VelásquezUCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
Payam NahidUCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
Andrew VernonCenters for Disease Control and Prevention, Atlanta, GA, USA.
Ekaterina V KurbatovaCenters for Disease Control and Prevention, Atlanta, GA, USA.
Susan SwindellsUniversity of Nebraska Medical Center, Omaha, NE, USA.
Richard E ChaissonCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MA, USA.ORCID http://orcid.org/0000-0003-4710-925X
Susan E DormanMedical University of South Carolina, Charleston, SC, USA.
John L JohnsonCase Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.ORCID http://orcid.org/0000-0003-1783-0476
Marc WeinerUniversity of Texas Health Science Center at San Antonio and the South Texas Veterans Health Care System, San Antonio, TX, USA.
Amina JindaniSt. George's, University of London, London, UK.
Thomas HarrisonSt. George's, University of London, London, UK.
Erin E SizemoreCenters for Disease Control and Prevention, Atlanta, GA, USA.
William WhitworthCenters for Disease Control and Prevention, Atlanta, GA, USA.
Wendy CarrCenters for Disease Control and Prevention, Atlanta, GA, USA.
Kia E BryantCenters for Disease Control and Prevention, Atlanta, GA, USA.
Deron BurtonCenters for Disease Control and Prevention, Atlanta, GA, USA.
Kelly E DooleyDivision of Infectious Diseases, Vanderbilt University, Nashville, TN, USA.
Melissa EngleUniversity of Texas Health Science Center at San Antonio and the South Texas Veterans Health Care System, San Antonio, TX, USA.
Pheona NsubugaUganda-Case Western Reserve University Research Collaboration, Kampala, Uganda.
Andreas H DiaconTASK, Cape Town, Western Cape, Cape Town, South Africa.
Nguyen Viet NhungVietnam National Tuberculosis Program-University of California, San Francisco Research Collaboration Unit, Hanoi, Vietnam.
Rodney DawsonLung Institute and Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Radojka M SavicDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA. rada.savic@ucsf.edu.ORCID http://orcid.org/0000-0003-3143-5579
AIDS Clinical Trial Group
Tuberculosis Trials Consortium

Funding

AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplicationUM1AI069463 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI REES, HELEN, SANNE, IAN MATTHIAS · 2012 to 2025
$31.8M
Units for HIV/AIDS Clinical Trials NetworksU01AI069463 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI SANNE, IAN MATTHIAS · 2007 to 2011
$24.2M
NIAID NIH HHS P30 AI094189NIAID NIH HHS U01 AI068636NIAID NIH HHS U01 AI069463NIAID NIH HHS UM1 AI069463
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40360559
PMCPMC12075736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.